Clinical relevance of endothelin B-mediated vasoconstriction in lambs with increased pulmonary blood flow.
Langleben
David
D
D000818:Animals; D004149:Dioxoles / Q000494:pharmacology*; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1 / Q000819:agonists / Q000494:pharmacology / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D044022:Receptor, Endothelin A / Q000502:physiology; D012756:Sheep; D014655:Vascular Resistance / Q000187:drug effects* / Q000502:physiology; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D004149:Dioxoles; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1; D009842:Oligopeptides; C093321:PD 156707; D010880:Piperidines; D044022:Receptor, Endothelin A; D014662:Vasoconstrictor Agents; C086539:BQ 788